• Products
  • Solutions
    • Administrator
      • Ambulatory Surgery Center Solutions
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Clinician
      • Ambulatory Surgery Center Solutions
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • Cervical Cancer Screening Portfolio
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Stone Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Distributor
      • BD Original Equipment Manufacturing (OEM)
    • Drug Development Company
      • Drug Delivery Systems
    • Medical Device Manufacturer
      • BD Original Equipment Manufacturing (OEM)
    • Laboratory
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • Cervical Cancer Screening Portfolio
      • Diagnostic Accuracy and Efficiency
      • Integrated Diagnostic Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Traditional Microbiology
    • Pharmacy
      • Hazardous Drug Safety
      • Integrated Diagnostic Solutions
      • Patient Safety Solutions
      • Medication Management Solutions
      • Sepsis Management
      • Vascular Access Management (VAM)
    • Surgery
      • Ambulatory Surgery Center Solutions
      • Hernia Repair Solutions
      • Patient Safety Solutions
      • Surgical Solutions
      • Venous technology
  • Knowledge Center
    • Events
    • Literature
    • Training
  • Support
  • About BD
    • Our Company
      • About Us
      • Segments
      • Leadership
      • Ethics and Compliance
    • Cybersecurity at BD
      • About Us
      • Trust Center
      • Bulletins and Patches
      • Disclosure Process
      • Helpful Resources
    • Distributors
      • Distributor List
      • Unique device identifier (UDI)
    • ESG (Environmental, Social, and Governance)
      • Global Health
      • Sustainability
      • Social Investing
      • Inclusion, Diversity & Equity
    • Global External Funding Opportunities
    • Investors
    • Innovation at BD
      • Overview
      • BD Idea Submission Process
    • News, Media and Blogs
    • Policies, Guidelines and Statements Center
    • Quality
    • Recent Mergers and Acquisitions
    • Response to COVID-19
      • Rapid COVID-19 Testing
      • Tools and Trainings
      • Support Offerings
    • Suppliers
      • Corporate Policies and Expectations
      • Doing Business with BD
      • Global Procurement
      • Supplier Programs
  • Careers
  • Country United States
  • Login here Login
Skip to main content Skip to section navigation Skip to footer
Becton, Dickinson and Company
  • Products
  • Solutions
    • Administrator
      • Ambulatory Surgery Center Solutions
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Clinician
      • Ambulatory Surgery Center Solutions
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • Cervical Cancer Screening Portfolio
      • Diagnostic Accuracy and Efficiency
      • Hazardous Drug Safety
      • Medication Management Solutions
      • Patient Safety Solutions
      • Sepsis Management
      • Stone Management
      • Surgical Solutions
      • Targeted Temperature Management
      • Vascular Access Management (VAM)
    • Distributor
      • BD Original Equipment Manufacturing (OEM)
    • Drug Development Company
      • Drug Delivery Systems
    • Medical Device Manufacturer
      • BD Original Equipment Manufacturing (OEM)
    • Laboratory
      • Antimicrobial Resistance
      • BD Original Equipment Manufacturing (OEM)
      • Cervical Cancer Screening Portfolio
      • Diagnostic Accuracy and Efficiency
      • Patient Safety Solutions
      • Sepsis Management
      • Traditional Microbiology
    • Pharmacy
      • Hazardous Drug Safety
      • Patient Safety Solutions
      • Medication Management Solutions
      • Sepsis Management
      • Vascular Access Management (VAM)
    • Surgery
      • Ambulatory Surgery Center Solutions
      • Hernia Repair Solutions
      • Patient Safety Solutions
      • Surgical Solutions
      • Venous technology
  • Knowledge Center
    • Events
    • Literature
    • Training
  • Support
  • About BD
    • Our Company
      • About Us
      • Segments
      • Leadership
      • Ethics and Compliance
    • Cybersecurity at BD
      • About Us
      • Trust Center
      • Bulletins and Patches
      • Disclosure Process
      • Helpful Resources
    • Distributors
      • Distributor List
      • Unique device identifier (UDI)
    • ESG (Environmental, Social, and Governance)
      • Global Health
      • Sustainability
      • Social Investing
      • Inclusion, Diversity & Equity
    • Global External Funding Opportunities
    • Investors
    • Innovation at BD
      • Overview
      • BD Idea Submission Process
    • News, Media and Blogs
    • Policies, Guidelines and Statements Center
    • Quality
    • Recent Mergers and Acquisitions
    • Response to COVID-19
      • Rapid COVID-19 Testing
      • Tools and Trainings
      • Support Offerings
    • Suppliers
      • Corporate Policies and Expectations
      • Doing Business with BD
      • Global Procurement
      • Supplier Programs
  • Careers
  • Country

    United States

    • North America
      • Canada (FR)
      • Canada (EN)
      • Mexico
      • United States
    • South America
      • Argentina
      • Brasil
      • Chile
      • Colombia
    • Europe
      • Belgium (FR)
      • Belgium (NL)
      • Česká republika
      • Denmark
      • Europe
      • Suomi
      • France
      • Deutschland
      • Hebrew
      • Hungary (EN)
      • Hungary (HU)
      • United Kingdom
      • Ireland
      • Italia
      • Nederland
      • Norge
      • Polska
      • Россия
      • España
      • Sverige
      • Schweiz
      • Türkiye
      • United Kingdom
    • Middle East / Africa
      • Middle East, North Africa
      • Africa
    • Asia / Pacific
      • Australia / New Zealand
      • 中国
      • Greater Asia
      • India
      • Indonesia
      • 日本
      • Korea
      • Malaysia
      • Philippines
      • Singapore
      • Thailand
      • Vietnam
  • Login here

    Login

  • Country

    United States

    North America
    • Canada (FR)
    • Canada (EN)
    • Mexico
    • United States
    South America
    • Argentina
    • Brasil
    • Chile
    • Colombia
    Europe
    • Belgium (FR)
    • Belgium (NL)
    • Česká republika
    • Denmark
    • Europe
    • Suomi
    • France
    • Deutschland
    • Hebrew
    • Hungary (EN)
    • Hungary (HU)
    • United Kingdom
    • Ireland
    • Italia
    • Nederland
    • Norge
    • Polska
    • Россия
    • España
    • Sverige
    • Schweiz
    • Türkiye
    • United Kingdom
    Middle East / Africa
    • Middle East, North Africa
    • Africa
    Asia / Pacific
    • Australia / New Zealand
    • 中国
    • Greater Asia
    • India
    • Indonesia
    • 日本
    • Korea
    • Malaysia
    • Philippines
    • Singapore
    • Thailand
    • Vietnam
    Close
  • Login Here

    Login

Historical Data

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • BD Innovates
    • Email Alerts
  • Company Info
    • Overview
    • Executive Leadership
    • Annual Reports & Proxy
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Credit Rating
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
    • Stock Split History
    • Dividends
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • ESG
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
    • Contact the Board
    • Reporting Accounting, Internal Accounting Controls or Auditing Matters
  • Stock Data

  • Quote and Chart
  • Historical Data
  • Analyst Coverage
  • Stock Split History
  • Dividends
By reading this content you are acknowledging our forward looking statement.

Forward Looking Statement

The information included on this website and other information provided from time to time through webcasts, conference calls, securities analyst meetings, road show presentations, investor conferences, newsletters and similar events and communications contains forward-looking statements (as defined under Federal securities laws) based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of BD may differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “may,” “anticipate,” “estimate” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.

All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Many of these risks and uncertainties are beyond the company's control. For a discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements see our latest Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.

  • Email Alerts
  • Contacts
  • RSS News Feed
  • Sitemap
  • Follow us
    • Linked In
    • Facebook
    • Instagram
    • Twitter
    • Youtube
Quick Links
  • Recalls and Field Actions
  • Careers
  • Cybersecurity
  • Electronic Instructions for Use
  • Events
  • Investors
  • Inclusion, Diversity & Equity
  • Literature
  • Live Chat Support
  • News, Media and Blogs
  • Our Company
  • Ethics and Compliance
  • Support
  • Training
Becton, Dickinson and Company

©2023 BD. All rights reserved. BD and the BD Logo are trademarks of Becton, Dickinson and Company. All other trademarks are the property of their respective owners.

  • Contact us
  • Cookie Preferences
  • Privacy
  • Terms of Use
  • Website Accessibility
  • Your Privacy Rights
  • Limit the use of Sensitive Personal Information

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.